Medlive Technology Co., Ltd.

HKEX:2192.HK

8.85 (HKD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 121.722121.722119.249119.24986.75386.75391.05191.05165.97765.97776.8976.8965.33165.33162.35562.35544.4144.41
Cost of Revenue 48.05748.05746.19346.19334.14234.14230.30230.30220.35520.35523.77523.77518.07818.07816.43216.43212.21512.215
Gross Profit 73.66573.66573.05673.05652.61252.61260.74960.74945.62245.62253.11553.11547.25347.25345.92345.92332.19532.195
Gross Profit Ratio 0.6050.6050.6130.6130.6060.6060.6670.6670.6910.6910.6910.6910.7230.7230.7360.7360.7250.725
Reseach & Development Expenses 15.33815.33817.83417.8349.2949.29414.69414.6948.4228.4228.0668.0664.64.63.8753.8753.9763.976
General & Administrative Expenses 38.01738.01741.98941.98928.6628.6634.65334.65325.49425.49428.35228.35222.19822.1988.5028.5027.3787.378
Selling & Marketing Expenses 8.3228.3228.3898.389886.3926.3928.0578.0575.3295.3297.597.595.9545.9544.0654.065
SG&A 46.33846.33851.90551.90536.6636.6642.1242.1233.55133.55134.04734.04729.78829.78814.89614.89611.44311.443
Other Expenses 000000000000000000
Operating Expenses 61.67661.67669.73948.88942.36742.36733.58433.58438.48438.48439.60839.60829.44929.44914.69114.69111.44211.442
Operating Income 11.98911.9893.31822.51410.05410.05425.83925.8394.074.0713.37113.37117.43117.43131.00731.00720.7520.75
Operating Income Ratio 0.0980.0980.0280.1890.1160.1160.2840.2840.0620.0620.1740.1740.2670.2670.4970.4970.4670.467
Total Other Income Expenses Net 67.08567.08571.91752.72141.27841.27824.73524.73512.87612.8763.3563.3560.8060.8060.6080.6080.060.06
Income Before Tax 79.07479.07475.23575.23551.33251.33250.57350.57316.94616.94616.72716.72718.23718.23731.61531.61520.8120.81
Income Before Tax Ratio 0.650.650.6310.6310.5920.5920.5550.5550.2570.2570.2180.2180.2790.2790.5070.5070.4690.469
Income Tax Expense 2.7212.7210.1840.1840.5020.5021.1951.1953.1133.1133.9273.9278.4148.4146.2746.2743.5523.552
Net Income 73.3673.3671.79271.79249.35949.35945.17445.17413.48713.48710.48610.4869.8239.82325.34125.34117.25817.258
Net Income Ratio 0.6030.6030.6020.6020.5690.5690.4960.4960.2040.2040.1360.1360.150.150.4060.4060.3890.389
EPS 0.0990.0990.0980.0980.0670.0670.0620.0620.0180.0180.0150.0150.0180.0180.0470.0470.0320.032
EPS Diluted 0.0990.0990.0980.0980.0670.0670.0620.0620.0180.0180.0150.0150.0180.0180.0470.0470.0320.032
EBITDA 28.30928.30923.60623.60610.91910.91926.18626.1864.6754.67513.75513.75518.11218.11231.67231.67221.41421.414
EBITDA Ratio 0.2330.2330.1980.1980.1260.1260.2880.2880.0710.0710.1790.1790.2770.2770.5080.5080.4820.482